The THERACAT Project gets off to a flying start!
Earlier this week Biogelx’s Head of Technical Services, Dr Laura Goldie and our Marie Skłodowska-Curie Early Stage Research Africa Galvez Flores headed to Eindhoven for the first THERACAT Network Meeting.
The meeting was held at the Institute for Complex Molecular Systems at the Technical University Eindhoven and brought together 13 consortium members from both academia and industry. It was an opportunity for the Principal Investigators to share their institutions expertise and facilities and for the new THERACAT research fellows to introduce themselves and their planned projects all focussed around the development of novel cancer treatments. With a range of expertise from organic chemistry, catalysis, biomaterials, cancer biology, microscopy, and bioprinting the meeting was a great platform to network, share ideas, and learn about what each member can bring to each specific research project. For Biogelx’s ESR Africa’s project, the focus is on the development of realistic 3D cancer models using Biogelx proprietary peptide hydrogel technology. These models will be used to test the delivery and effectiveness of bio-orthogonal catalytic systems for the treatment of cancer developed by other consortium members.
THERACAT is a Horizon2020 funded Marie Skłodowska-Curie European Training Network (H2020-MSCA-ITN-2017, Project 765497). This multidisciplinary programme will train 13 early stage researchers, with the combination of research expertise, cutting-edge facilities, and the complementary skills present in the consortium providing a great platform for the advancement of their careers, as well as of the knowledge of catalysis-based anticancer therapies.
You might like: